Breaking News Instant updates and real-time market news.

MASI

Masimo

$113.85

-1.94 (-1.68%)

08:10
10/25/18
10/25
08:10
10/25/18
08:10

Masimo announces FDA clearance for Masimo RD sensors

Masimo announced that RD SET sensors with Masimo Measure-through Motion and Low Perfusion SET pulse oximetry have received FDA clearance with improved SpO2 accuracy specifications for all patients greater than 3 kg. RD SET single-patient-use sensors with the improved accuracy specifications are now available. The new RD SET sensors' SpO2 accuracy specifications during patient motion have improved for adult, pediatric, and infant patients to 1.5%, compared to previous accuracy specifications of 3%. In addition to offering improved accuracy, RD SET sensors are designed to enhance patient comfort, optimize clinician workflows, and help hospitals meet green initiatives. The sensors are lightweight and have a flat, soft cable with smooth edges, so that they lie comfortably on a patient's hand or foot. The sensors feature an intuitive sensor-to-cable connection. Their lightweight design results in up to 84% less waste, and their sleek, recyclable packaging reduces storage and shipping space.

  • 31

    Oct

MASI Masimo
$113.85

-1.94 (-1.68%)

03/09/18
03/09/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Corcept Therapeutics (CORT) initiated with a Buy at B. Riley FBR. 2. Masimo (MASI) initiated with an Overweight at Barclays. 3. Ovid Therapeutics (OVID) initiated with an Overweight at Piper Jaffray. 4. Endocyte (ECYT) initiated with an Outperform at Wells Fargo. 5. Cloudera (CLDR) initiated with a Neutral at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/02/18
PIPR
05/02/18
NO CHANGE
Target $94
PIPR
Neutral
Masimo price target raised to $94 from $91 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target on Masimo to $94 after its Q1 earnings beat and raised guidance for FY18, saying the company's driver shipments in the quarter reflects the ongoing strength of its Signal Extraction Technology - SET - business. The analyst further cites the management's commentary that growth was evident in both the U.S. and the overseas markets while also pointing to the company's expected stock buybacks being favored over large M&A deals. Quirk keeps his Neutral rating on Masimo, stating that despite the better than expected results, the company's risk-reward is balanced at current levels.
09/14/18
NEED
09/14/18
INITIATION
Target $139
NEED
Buy
Masimo initiated with a Buy at Needham
Needham analyst Mike Matson initiated Masimo with Buy rating and a price target of $139, saying the "medical world is beating a path to its door" after the company has built a "better pulse oximeter". The analyst sees the company's Philips partnership accelerating its product revenue growth, even though the overall revenue growth and margins will likely be constrained by the upcoming "royalty and other revenue cliff". Matson still contends that Masimo can deliver upside in earnings and believes that consensus is too conservative, but also notes that the stock trades at a 21% premium in forward earnings multiple relative to its medical device peers.
09/14/18
09/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Shopify (SHOP) and Angi Homeservices (ANGI) initiated with an Outperform at Wedbush. 2. Griffon (GFF) initiated with a Neutral at Baird. 3. Genprex (GNPX) initiated with a Buy at Maxim. 4. Zogenix (ZGNX) initiated with a Buy at BofA/Merrill. 5. Masimo (MASI) initiated with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TOL

Toll Brothers

$38.34

0.82 (2.19%)

16:31
05/21/19
05/21
16:31
05/21/19
16:31
Earnings
Toll Brothers reports Q2 EPS 87c, consensus 75c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

MYL

Mylan

$19.67

0.225 (1.16%)

16:30
05/21/19
05/21
16:30
05/21/19
16:30
Hot Stocks
FDA: Mylan broadens recall of Valsartan tablets »

Mylan N.V.External Link…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

16:30
05/21/19
05/21
16:30
05/21/19
16:30
Options
Preliminary option volume of 15.0M today »

Preliminary option volume…

CDAY

Ceridian

$51.19

1.04 (2.07%)

16:29
05/21/19
05/21
16:29
05/21/19
16:29
Syndicate
Ceridian files to sell 8M shares of common stock for holders »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IT

Gartner

$154.12

1.62 (1.06%)

16:25
05/21/19
05/21
16:25
05/21/19
16:25
Hot Stocks
Gartner VP Robin Kranich sellls over $980K in company shares »

Gartner VP Robin Kranich…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 03

    Jun

  • 05

    Jun

PSTG

Pure Storage

$20.60

0.6 (3.00%)

16:22
05/21/19
05/21
16:22
05/21/19
16:22
Hot Stocks
Pure Storage down 17% to $17.10 after Q1 results miss estimates »

The company's Q2 and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 20

    Jun

  • 09

    Jul

EXPR

Express

$3.45

0.08 (2.37%)

16:21
05/21/19
05/21
16:21
05/21/19
16:21
Hot Stocks
Express appoints Timothy Baxter CEO »

Express announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 12

    Jun

  • 18

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Earnings
Ooma narrows FY20 EPS view to (24c)-(19c) from (24c)-(14c), consensus (19c) »

Raises FY20 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

AVP

Avon Products

$3.20

0.06 (1.91%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Options
Avon Products put buyer closes out long term trade »

Avon Products put buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/21/19
05/21
16:20
05/21/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRBI

Red River Bancshares

$49.95

(0.00%)

16:19
05/21/19
05/21
16:19
05/21/19
16:19
Initiation
Red River Bancshares initiated  »

Red River Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNS

Transcat

$24.25

0.13 (0.54%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Hot Stocks
Transcat sees FY20 CapEx $7.8M-$9.2M »

Transcat expects its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

AYR

Aircastle

$20.03

0.275 (1.39%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Hot Stocks
Aircastle raises repurchase program up to $100M from $76M »

Aircastle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 13

    Nov

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Earnings
Ooma sees Q2 EPS (7c) to (5c), consensus (4c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/21/19
05/21
16:17
05/21/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNS

Transcat

$24.25

0.13 (0.54%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Earnings
Transcat reports Q4 EPS 35c, consensus 29c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

RDNT

RadNet

$13.62

0.37 (2.79%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Hot Stocks
RadNet officer John Crues sells 20K shares of company stock »

RadNet officer John Crues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

PRSP

Perspecta

$22.33

0.36 (1.64%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Hot Stocks
Perspecta increases quarterly dividend 20% »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Syndicate
LiqTech files to sell common stock, no amount given »

Stephens Inc. is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Syndicate
LiqTech files to sell common stock, no amount given »

Stephens is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Earnings
Ooma reports Q EPS (4c), consensus (5c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 10

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/21/19
05/21
16:16
05/21/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFUS

Littelfuse

$170.78

1.7 (1.01%)

16:15
05/21/19
05/21
16:15
05/21/19
16:15
Initiation
Littelfuse initiated  »

Littelfuse initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

LUV

Southwest

$53.37

1.37 (2.63%)

16:15
05/21/19
05/21
16:15
05/21/19
16:15
Hot Stocks
Southwest says new AMFA contract 'benefits all parties' »

Southwest Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 25

    Jul

  • 13

    Nov

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

16:13
05/21/19
05/21
16:13
05/21/19
16:13
Earnings
Urban Outfitters reports Q1 EPS 31c, consensus 25c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.